Crafoord Prize Symposium in Polyarthritis 2017-05-17
— The control of inflammation; regulatory T cells in health and disease
Targeting transcriptional and epigenetic control of Treg cell development, Crafoord Laureate 2017, Shimon Sakaguchi, Osaka University, Osaka, Japan.
History of FoxP3 and implications for therapeutic intervention in disease, Crafoord Laureate 2017, Fred Ramsdell, Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
Regulatory T Cell Differentiation, Crafoord Laureate 2017, Alexander Rudensky, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Unraveling central tolerance through multi-organ autoimmunity, Mark Anderson, Diabetes Center, University of California, San Francisco, CA, USA.
CTLA-4 and T regulatory cells in autoimmunity, Kajsa Wing, Karolinska Institutet, Stockholm, Swede.
Targeting Fibroblasts to regulate inflammation, Christopher Buckley, Institute of Inflammation and Ageing, University of Birmingham, UK
IPEX Syndrome: Clinical History, Immunological Characterization and Therapeutic Perspectives, Rosa Bacchetta, Stanford University, CA, USA.
Switching off rheumatoid arthritis – vain hope or future reality?, John D Isaacs, Institute of Cellular Medicine, Newcastle University, UK.
CD4+ T cells in Rheumatoid Arthritis – the questions of subsets, time and location, Vivianne Malmström, Karolinska Institutet, Stockholm, Sweden.
Manipulating Tregs to control tolerance in autoimmunity and cancer, Jeffrey A. Bluestone, Hormone Research Institute, University of California, San Francisco, CA, USA